HB 712 requires Tennessee's Department of Disability and Aging and TennCare to create and publish guidelines for hiring family members as caregivers for individuals with disabilities receiving Medicaid services. It prohibits service providers from denying employment to qualified family caregivers based on factors like family relationships, residence, age, guardianship status, or specific Medicaid waiver programs (including Katie Beckett and self-determination waivers). The bill also prevents providers from reducing benefits for individuals with disabilities solely because care is provided by a family member, unless through the person-centered planning process. This directly affects family caregivers seeking employment, disability service providers, and individuals receiving long-term care services under Tennessee's Medicaid programs.
HB 243 extends the legal existence of Tennessee's Department of Mental Health and Substance Abuse Services until June 30, 2029, preventing its automatic termination. The bill amends Tennessee Code Annotated sections 4-29-246 and 4-29-250 to remove the department's previous sunset date and formally define it within state law. This affects the department's ongoing operations and the Tennessee residents who rely on its services. The law became effective April 29, 2025, after passing through the legislature.
SB 440 clarifies that standalone dental and vision insurance plans (known as "excepted benefits") are not required to cover specific medical treatments, services, or conditions unless state law explicitly mandates it. This change directly affects health insurance plans offering these stand-alone benefits, removing an implied obligation to cover certain medical needs under those plans. The law applies to all new or renewed insurance policies issued on or after July 1, 2025, ensuring clarity for insurers and policyholders. It does not alter existing coverage requirements for standard health insurance plans.
SB 940 expands Tennessee's "Good Samaritan" law to include alcohol-related overdoses, allowing people to seek medical help for alcohol poisoning without facing prosecution for alcohol violations. The bill amends Tennessee Code Annotated Title 63 by updating definitions to replace "drug overdose" with "overdose" and "drug violation" with "drug or alcohol violation" throughout the law. This change directly affects individuals experiencing or witnessing alcohol overdoses, as well as those providing emergency assistance. The policy removes legal barriers to calling for help during alcohol-related medical emergencies, treating alcohol and drug overdoses equally under the immunity provision. The law takes effect July 1, 2025.
SB 299 amends Tennessee's medical cannabis commission membership requirements to include a patient caregiver (or former caregiver of a deceased patient) and a subject matter expert in cannabis cultivation, processing, distribution, or medical prescription. The bill also updates the commission's reporting duties to explicitly allow it to provide policy recommendations to the legislature alongside its findings. These changes, effective April 15, 2025, directly affect how the commission is structured and the scope of its advice to lawmakers on medical cannabis policy.
SB 849 requires Tennessee medical and osteopathic boards to create an optional continuing education course on maternal mental health for healthcare professionals. It directly affects physicians specializing in obstetrics/gynecology, pediatrics, and psychiatry, as well as certain psychologists. The course must cover screening practices, types of maternal mental health disorders, evidence-based treatments, and when to consult a psychiatrist. Boards must update the curriculum periodically to reflect new research and accept course completion as credit toward required continuing education.
SB 1146 requires county medical examiners to test decedents involved in mass shootings (resulting in four or more deaths) for all drugs, including psychotropic medications used for mental health conditions. It mandates anonymized data sharing with the University of Tennessee Health Science Center and the Department of Health, prohibiting disclosure of identifying information. The health science center must study drug interactions and submit quarterly reports to legislative health committees. The law, effective July 1, 2025, applies to medical examiners, health agencies, and the University of Tennessee, while requiring compliance with privacy laws.
SB 955, now known as the "Medical Ethics Defense Act," protects Tennessee healthcare providers from being forced to participate in or pay for medical procedures that conflict with their conscience. It defines "conscience" as sincerely held ethical, moral, or religious beliefs and prohibits discriminatory actions - like termination or penalties - against providers who refuse specific procedures based on those beliefs. The law also safeguards providers who report violations of this act, preventing retaliation for whistleblowing. This applies to healthcare professionals, institutions, and payers but excludes procedures governed by federal law (such as emergency care under EMTALA).
SB 449, the "Fertility Treatment and Contraceptive Protection Act," establishes legal rights for individuals in Tennessee to access fertility treatments and contraception without state prohibition. It defines "fertility treatment" broadly to include procedures like in vitro fertilization, genetic testing of embryos, and medication for fertility, while defining "contraception" to cover methods such as birth control pills, emergency contraceptives, and sterilization. The law explicitly states that Tennessee law does not prohibit these activities, overriding conflicting state laws. This act takes effect on July 1, 2025, directly affecting all residents seeking these health services within the state.
HB 1198 requires Tennessee health insurers and TennCare to allow patients to try biosimilar drugs (cost-effective copies of brand-name medications) before covering the original branded drug. It amends state law to permit health carriers to mandate a biosimilar trial for equivalent branded prescriptions, removing prior requirements for generic drug trials. The bill also directs TennCare’s pharmacy committee to consider biosimilar drugs when recommending medications for the state’s preferred drug list. These changes aim to reduce prescription drug costs by increasing biosimilar adoption, as stated in the bill’s legislative findings.
